Good to know that Reuters has regained acceptance from V&C1.
I have to ask though folks, given that as of Jan 4 2023 - 12 days ago - neither Moderna, Pfizer, nor GlaxoSmithKline have received FDA approval to market an RSV vaccine, what a year old announcement of a trial has to do with anything.
mass immunosuppression
She probably should try to provide some support for that statement. It seems funny since the vaccines are designed to give the immune system a heads-up that a new pathogen might arrive.
Good to know that Reuters has regained acceptance from V&C1.
I have to ask though folks, given that as of Jan 4 2023 - 12 days ago - neither Moderna, Pfizer, nor GlaxoSmithKline have received FDA approval to market an RSV vaccine, what a year old announcement of a trial has to do with anything.
She probably should try to provide some support for that statement. It seems funny since the vaccines are designed to give the immune system a heads-up that a new pathogen might arrive.